Ovation Science Secures New Canadian Patent; Strengthening IP Position and Expanding Commercial Opportunities for Topical Cannabis Products

Core Viewpoint - Ovation Science Inc. has received a new Canadian patent that enhances its market exclusivity and expands its global intellectual property portfolio, supporting long-term revenue growth [1] Group 1: Patent Issuance - The newly issued Canadian patent covers proprietary topical formulations containing CBD and THC [1] - The patent is titled "Composition and method for transdermal delivery of cannabidiol (CBD) and delta9-tetrahydrocannabinol (THC)" [1] - This patent expands Ovation's intellectual property protection beyond its previously issued U.S. patent [1] Group 2: Market Implications - The issuance of the patent significantly strengthens the Company's growing international patent portfolio [1] - The patent enhances the Company's market exclusivity and licensing potential [1]